As with TCGA Pan-Cancer Atlas data, patients with below-median PI24 scores expressed high levels of immunoglobulin genes, CD8A, and chemokine genes (CCL4, CCL5, and CXCL10), and had significantly higher PFS and OS rates (P = 0.00041 and P = 0.0011, respectively; Figure 10F). This evidence concerns the gene CCL5 and cancer.